{{medical}}
{{Infobox interventions |
  Name        = 水分置換療法<br>Aquapheresis |
  Image       = |
  Caption     = |
  ICD10       = |
  ICD9unlinked = {{ICD9proc|99.78}} |
  MeshID      = |
  OPS301      = |
  OtherCodes  = |
}}

'''水分置換療法'''（aquapheresis、置換治療），旨在從一位患有[[高血容量症|高血容量症]](hypervolemia/fluid overload)病徵的患者身體以安全地，可以預見地，並有效地移除多餘的鹽及水的一種[[保健醫療技術|保健醫療技術]](Health technology)。

水分置換療法移除患者身體上多餘的鹽和水分，並幫助患者恢復的適當的[[液體平衡|液體平衡]](fluid balance/流體平衡)、此即所謂的〈等量體液維持法(euvolemia)〉。

==用途==
{{see also|膠體滲透壓}}

水分置換療法用於治療一種名為"液體超負荷(流體過載)"和"[[高血容量症|高血容量症]](Hypervolemia)"病徵的療法。液體超負荷可以由許多原因，包括[[心臟衰竭|心臟衰竭]]、[[肝硬化|肝硬化]]，[[高血壓|高血壓]]和某些[[腎病變|腎病變]]等疾病所引起的。液體超負荷也可以產生於某些[[外科学|外科]]手術後的[[預後|預後]]情況。[[心臟衰竭|充血性心臟衰竭]]是液體超負荷的最常見原因。

==運行機制==
*通過一個特殊的過濾器、使用外週或中央靜脈[[導管|導管]](Catheter)抽出患者含有過量鹽和水的血液。使用一種[[超滤|超滤]]的形式，該過濾器從血液中分離過量的鹽和水。而這些流體(過量的鹽和水)被收集在一個袋子裡以便之後進行處理，接著將血液再輸送回至患者。
*抗凝血治療常與水分置換療法一起使用於防止血液在超濾過濾器上凝固。<!--Patients must discontinue any anticoagulant medications before starting aquapheresis so they can be placed on intravenous [[Heparin|Heparin]] therapy. Once the Heparin therapy is initiated, the patient's PTT (partial thromboplastin time) levels will be monitored closely per hospital protocol to prevent excessive anti-coagulation. If a patient is allergic to Heparin or has a condition known as Heparin-induced Thrombocytopenia (HIT), an alternative intravenous anti-coagulate may be used.-->
*血液不到一分鐘的時間流到體外、且血液流出的總量為33毫升（2.5湯匙）。因此，這是一種[[體外_(醫學)|體外]]治療。
*最多每小時可除去過量的流體500[[毫升|毫升]](1[[品脫|品脫]])。平均去除率為每小時250毫升（1/2品脫）。<!--
* The fluid removed is [[Isotonicity|isotonic]] to blood and therefore [[electrolyte|electrolyte]] balance is maintained throughout therapy and up to 3.2 grams of sodium per liter can be removed.-->
*水分置換療法由三個基本部分組成：一座控制台（具有兩個泵浦）、血液過濾電路，以及靜脈導管。

==註釋==
{{refbegin|2}}
*{{cite journal |vauthors=Costanzo MR, Guglin ME, Saltzberg MT |title=Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure |journal=J Am Coll Cardiol |volume=49 |issue=6 |pages=675–83 |date=Feb 2007 |pmid=17291932 |doi=10.1016/j.jacc.2006.07.073 |display-authors=etal}}
*{{cite journal |vauthors=Costanzo MR, Guglin ME, Saltzberg MT |title=Ultrafiltration is Associated With Fewer Rehospitalizations than Continuous Diuretic Infusion in Patients With Decompensated Heart Failure: Results From UNLOAD |journal=J Card Fail |volume=16 |issue=4 |pages=277–84 |year=2010 |doi=10.1016/j.cardfail.2009.12.009 |pmid=20350693 |display-authors=etal}}
*{{cite journal |vauthors=Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P |title=Early ultrafiltration in patients with decompensated heart failure and diuretic resistance |journal=J Am Coll Cardiol |volume=46 |issue=11 |pages=2047–51 |date=Dec 2005 |pmid=16325040 |doi=10.1016/j.jacc.2005.05.099 |url=}}
*{{cite journal |vauthors=Bart BA, Boyle A, Bank AJ |title=Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial |journal=J Am Coll Cardiol |volume=46 |issue=11 |pages=2043–6 |date=Dec 2005 |pmid=16325039 |doi=10.1016/j.jacc.2005.05.098 |display-authors=etal}}
*{{cite journal |vauthors=Jaski BE, Ha J, Denys BG, Lamba S, Trupp RJ, Abraham WT |title=Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients |journal=Journal of Cardiac Failure |volume=9 |issue=3 |pages=227–31 |date=Jun 2003 |pmid=12815573 |doi=10.1054/jcaf.2003.28 }}
*{{cite journal |vauthors=Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P |title=Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure |journal=J Am Coll Cardiol. |volume=38 |issue=4 |pages=963–8 |date=Oct 2001 |pmid=11583865 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(01)01479-6 |doi=10.1016/S0735-1097(01)01479-6 |access-date=2016-08-01 |archive-date=2019-06-06 |archive-url=https://web.archive.org/web/20190606161055/https://linkinghub.elsevier.com/retrieve/pii/S0735-1097(01)01479-6 |dead-url=no }}
*{{cite journal |vauthors=Agostoni P, Marenzi G, Lauri G |title=Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result |journal=Am J Med. |volume=96 |issue=3 |pages=191–9 |date=Mar 1994 |pmid=8154506 |doi=10.1016/0002-9343(94)90142-2 |display-authors=etal}}
*{{cite journal |vauthors=Pepi M, Marenzi GC, Agostoni PG |title=Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates |journal=Br Heart J. |volume=70 |issue=2 |pages=135–40 |date=Aug 1993 |pmid=8038023 |pmc=1025273 |url=http://heart.bmj.com/cgi/pmidlookup?view=long&pmid=8038023 |doi=10.1136/hrt.70.2.135|display-authors=etal}}
*{{cite journal |vauthors=Agostoni PG, Marenzi GC, Pepi M |title=Isolated ultrafiltration in moderate congestive heart failure |url=https://archive.org/details/sim_journal-of-the-american-college-of-cardiology_1993-02_21_2/page/424 |journal=J Am Coll Cardiol. |volume=21 |issue=2 |pages=424–31 |date=Feb 1993 |pmid=8426008 |doi=10.1016/0735-1097(93)90685-T |display-authors=etal}}
*{{cite journal |author1=S. A. Hunt |author2=W. T. Abraham |author3=M. H. Chin |author4=A. M. Feldman |author5=G. S. Francis |author6=T. G. Ganiats |author7=M. Jessup |author8=M. A. Konstam |author9=D. M. Mancini |title=2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation |journal=Circulation |volume=119 |issue=14 |pages=e391–e479 |year=2009 |pmid=19324966 |doi=10.1161/CIRCULATIONAHA.109.192065 |url=http://circ.ahajournals.org/cgi/reprint/119/14/e391 |display-authors=etal |access-date=2016-08-01 |archive-date=2009-05-03 |archive-url=https://web.archive.org/web/20090503091727/http://circ.ahajournals.org/cgi/reprint/119/14/e391 |dead-url=no }}
*{{cite journal |vauthors=Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN |title=Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline |journal=J Card Fail |volume=16 |pages=475–539 |year=2010 |pmid=20610207 |url=http://www.heartfailureguideline.org/ |doi=10.1016/j.cardfail.2010.04.005 |issue=6 |access-date=2016-08-01 |archive-date=2016-10-21 |archive-url=https://web.archive.org/web/20161021102543/http://www.heartfailureguideline.org/ |dead-url=no }}
*{{cite journal |author1=Kenneth Dickstein |author2=Alain Cohen-Solal |author3=Gerasimos Filippatos |author4=John J.V. McMurray |author5=Piotr Ponikowski |author6=Philip Alexander Poole-Wilson |author7=Anna Stromberg |author8=Dirk J. van Veldhuisen |author9=Dan Atar |author10=Arno W. Hoes |author11=Andre Keren |author12=Alexandre Mebazaa |author13=Markku Nieminen |author14=Silvia Giuliana Priori |author15=Karl Swedberg |title=ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure |journal=Eur Heart J |volume=29 |pages=2388–2442 |year=2008 |pmid=18826876 |url=http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-HF-FT.pdf |issue=10 |doi=10.1016/j.ejheart.2008.08.005 |deadurl=yes |archiveurl=https://web.archive.org/web/20110726041607/http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-HF-FT.pdf |archivedate=2011-07-26 |access-date=2016-08-01 }}
*{{cite journal |author1=JG Howlett |author2=RS McKelvie |author3=JMO Arnold |title=Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials |journal=Can J Cardiol |volume=25 |issue=2 |pages=85–105 |year=2009 |pmid=19214293 |url=http://www.ccs.ca/download/consensus_conference/consensus_conference_archives/HF_up_2009.pdf |doi=10.1016/S0828-282X(09)70477-5 |pmc=2691911 |display-authors=etal |deadurl=yes |archiveurl=https://web.archive.org/web/20110706172502/http://www.ccs.ca/download/consensus_conference/consensus_conference_archives/HF_up_2009.pdf |archivedate=2011-07-06 |access-date=2016-08-01 }}
{{refend}}

==參閱==
{{div col|2}}
* [[液體平衡|液體平衡]](Fluid balance)
* [[利尿劑|利尿劑]]
* [[血液分離置換療法|血液分離置換療法]](Apheresis)
* [[心臟衰竭|心臟衰竭]]
* [[高血容量症|高血容量症]](Hypervolemia/液體超負荷/Fluid overload)
* [[腎超濾作用|腎超濾作用]](Ultrafiltration (renal))
* [[超滤|超滤]]
{{div col end}}

==外部連結==
* The UNLOAD Study: Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure. http://www.unloadstudy.com{{Wayback|url=http://www.unloadstudy.com/ |date=20141221231739 }}
* Google Search on Aquapheresis: http://www.google.com/search?hl=en&q=aquapheresis

[[Category:治療|Category:治療]]